Hearing in bisphosphonate-treated children with osteogenesis imperfecta: our experience in thirty six young patients.
Department of Endocrinology and Diabetes, Murdoch Children's, Research Institute, Royal Children's Hospital, Melbourne, Vic. 3052, Australia.
T H
TH
Ting
M R
MR
Zacharin
D000293:Adolescent; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D002648:Child; D004164:Diphosphonates / Q000627:therapeutic use*; D005260:Female; D006314:Hearing Loss, Conductive / Q000188:drug therapy* / Q000209:etiology*; D006320:Hearing Tests; D006801:Humans; D008297:Male; D010013:Osteogenesis Imperfecta / Q000150:complications* / Q000188:drug therapy*; D055815:Young Adult
D050071:Bone Density Conservation Agents; D004164:Diphosphonates